UNITY Biotechnology - Brochure

This presentation and the accompanying oral commentary contain forward-looking statements including statements related to UNITY’s
understanding of cellular senescence and the role it plays in diseases of aging, the potential for UNITY to develop therapeutics to slow, halt, or reverse diseases of aging, including for ophthalmologic and neurologic diseases, the potential for UNITY to successfully commence and
complete clinical studies of UBX1325 for DME, AMD, and other ophthalmologic diseases, the expected timing of enrollment and results of the
clinical trials in UBX1325, and UNITY’s expectations regarding the sufficiency of its cash runway.